4.6 Letter

Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types

Journal

JAMA ONCOLOGY
Volume 5, Issue 10, Pages 1504-1506

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2019.2963

Keywords

-

Categories

Funding

  1. National Key Research and Development Program of China [2018YFC1313300, 2017YFC1308900]
  2. Natural Science Foundation of Guangdong Province [2014A030312015]
  3. Pearl River Nova Program of Guangzhou [201610010068]
  4. Fundamental Research Funds for the Central Universities [14ykpy40]
  5. National Natural Science Foundation of China [80872011]
  6. Outstanding Young Talents Program of Sun Yat-sen University Cancer Center [16zxqk03]
  7. Young Physician Scientist Program of Sun Yat-sen University Cancer Center [16zxqk03]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available